Cargando…

Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide

SIMPLE SUMMARY: Besides the diagnosis of endometrial carcinoma (EC), the identification of EC subtypes is an important precondition for the effective treatment of the disease. Molecular factors have an important role in this context. Biomedical analysis is already very possible in experimental appro...

Descripción completa

Detalles Bibliográficos
Autores principales: Mustea, Alexander, Ralser, Damian J., Egger, Eva, Ziehm, Ulrike, Vivas, Sonia, Brock, Stephan, Jackson, David, Condic, Mateja, Meisel, Christian, Otten, Lucia, Laib, Anna, Cordova, Miguel Cubas, Hartmann, Rahel, Stein, Martin A., Koensgen, Dominique, Stope, Matthias B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093381/
https://www.ncbi.nlm.nih.gov/pubmed/37046713
http://dx.doi.org/10.3390/cancers15072053
_version_ 1785023572527284224
author Mustea, Alexander
Ralser, Damian J.
Egger, Eva
Ziehm, Ulrike
Vivas, Sonia
Brock, Stephan
Jackson, David
Condic, Mateja
Meisel, Christian
Otten, Lucia
Laib, Anna
Cordova, Miguel Cubas
Hartmann, Rahel
Stein, Martin A.
Koensgen, Dominique
Stope, Matthias B.
author_facet Mustea, Alexander
Ralser, Damian J.
Egger, Eva
Ziehm, Ulrike
Vivas, Sonia
Brock, Stephan
Jackson, David
Condic, Mateja
Meisel, Christian
Otten, Lucia
Laib, Anna
Cordova, Miguel Cubas
Hartmann, Rahel
Stein, Martin A.
Koensgen, Dominique
Stope, Matthias B.
author_sort Mustea, Alexander
collection PubMed
description SIMPLE SUMMARY: Besides the diagnosis of endometrial carcinoma (EC), the identification of EC subtypes is an important precondition for the effective treatment of the disease. Molecular factors have an important role in this context. Biomedical analysis is already very possible in experimental approaches. However, for clinical practice the procedures are often too complex, too expensive, and too time-consuming. In the present study, very good evaluated molecular markers were detected using an alternative method and compared with the original method. Analyses showed very good results. The important advantage of the new procedure is that the required molecular data can be obtained exclusively by sequencing. This may greatly simplify EC subtype classification and could be more easily incorporated into routine clinical diagnosis. ABSTRACT: Background: The Cancer Genome Atlas (TCGA) network (United States National Cancer Institute) identified four molecular endometrial cancer (EC) subtypes using an extensive multi-method approach. The aim of this study was to determine the four TCGA EC molecular subtypes using a single-method whole-exome sequencing (WES)-based approach provided by MH Guide (Molecular Health, Heidelberg, Germany). Methods: WES and clinical data of n = 232 EC patients were obtained from TCGA. The four TCGA EC molecular subtypes designated as (i) Mutated Polymerase ε (POLE), (ii) Microsatellite Instability (MSI), (iii) Copy Number (CN) low and, (iv) CN-high were determined using the MH Guide software. The prognostic value of the subtypes determined by MH Guide were compared with the TCGA classification. Results: Analysis of WES data using the MH Guide software led to the precise identification of the four EC molecular subtypes analogous to the TCGA classification. Both approaches displayed high concordance in terms of prognostic significance. Conclusions: The multi-method-based TCGA EC molecular subtypes can reliably be reproduced by the single-method-based MH Guide approach. The easy-to-implement single-method MH Guide approach represents a promising diagnostic tool.
format Online
Article
Text
id pubmed-10093381
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-100933812023-04-13 Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide Mustea, Alexander Ralser, Damian J. Egger, Eva Ziehm, Ulrike Vivas, Sonia Brock, Stephan Jackson, David Condic, Mateja Meisel, Christian Otten, Lucia Laib, Anna Cordova, Miguel Cubas Hartmann, Rahel Stein, Martin A. Koensgen, Dominique Stope, Matthias B. Cancers (Basel) Article SIMPLE SUMMARY: Besides the diagnosis of endometrial carcinoma (EC), the identification of EC subtypes is an important precondition for the effective treatment of the disease. Molecular factors have an important role in this context. Biomedical analysis is already very possible in experimental approaches. However, for clinical practice the procedures are often too complex, too expensive, and too time-consuming. In the present study, very good evaluated molecular markers were detected using an alternative method and compared with the original method. Analyses showed very good results. The important advantage of the new procedure is that the required molecular data can be obtained exclusively by sequencing. This may greatly simplify EC subtype classification and could be more easily incorporated into routine clinical diagnosis. ABSTRACT: Background: The Cancer Genome Atlas (TCGA) network (United States National Cancer Institute) identified four molecular endometrial cancer (EC) subtypes using an extensive multi-method approach. The aim of this study was to determine the four TCGA EC molecular subtypes using a single-method whole-exome sequencing (WES)-based approach provided by MH Guide (Molecular Health, Heidelberg, Germany). Methods: WES and clinical data of n = 232 EC patients were obtained from TCGA. The four TCGA EC molecular subtypes designated as (i) Mutated Polymerase ε (POLE), (ii) Microsatellite Instability (MSI), (iii) Copy Number (CN) low and, (iv) CN-high were determined using the MH Guide software. The prognostic value of the subtypes determined by MH Guide were compared with the TCGA classification. Results: Analysis of WES data using the MH Guide software led to the precise identification of the four EC molecular subtypes analogous to the TCGA classification. Both approaches displayed high concordance in terms of prognostic significance. Conclusions: The multi-method-based TCGA EC molecular subtypes can reliably be reproduced by the single-method-based MH Guide approach. The easy-to-implement single-method MH Guide approach represents a promising diagnostic tool. MDPI 2023-03-30 /pmc/articles/PMC10093381/ /pubmed/37046713 http://dx.doi.org/10.3390/cancers15072053 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Mustea, Alexander
Ralser, Damian J.
Egger, Eva
Ziehm, Ulrike
Vivas, Sonia
Brock, Stephan
Jackson, David
Condic, Mateja
Meisel, Christian
Otten, Lucia
Laib, Anna
Cordova, Miguel Cubas
Hartmann, Rahel
Stein, Martin A.
Koensgen, Dominique
Stope, Matthias B.
Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title_full Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title_fullStr Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title_full_unstemmed Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title_short Determination of the Cancer Genome Atlas (TCGA) Endometrial Cancer Molecular Subtypes Using the Variant Interpretation and Clinical Decision Support Software MH Guide
title_sort determination of the cancer genome atlas (tcga) endometrial cancer molecular subtypes using the variant interpretation and clinical decision support software mh guide
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093381/
https://www.ncbi.nlm.nih.gov/pubmed/37046713
http://dx.doi.org/10.3390/cancers15072053
work_keys_str_mv AT musteaalexander determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT ralserdamianj determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT eggereva determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT ziehmulrike determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT vivassonia determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT brockstephan determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT jacksondavid determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT condicmateja determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT meiselchristian determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT ottenlucia determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT laibanna determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT cordovamiguelcubas determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT hartmannrahel determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT steinmartina determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT koensgendominique determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide
AT stopematthiasb determinationofthecancergenomeatlastcgaendometrialcancermolecularsubtypesusingthevariantinterpretationandclinicaldecisionsupportsoftwaremhguide